突变体和抗突变体表型诱导的遗传变异在进化适应和癌症治疗中的意义和应用
1College of Pharmacy, Duksung Women's University, Seoul, 01369, Republic of Korea. whchung23@duksung.ac.kr.
Journal of microbiology (Seoul, Korea)
|December 15, 2023
概括
突变驱动进化和疾病,突变表型增加癌症风险. 研究酵母揭示了与人类癌症和衰老相关的基因组不稳定机制.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 进化生物学 进化生物学
背景情况:
- 由DNA错误或损伤引起的突变会导致遗传变异和进化,也会导致癌症和衰老等疾病.
- 突变型表型,以高突变率为特征,在恶性瘤中突出,并与进化适应有关.
研究的目的:
- 审查影响突变速率的细胞通路.
- 探索突变基因及其表型在疾病,特别是癌症中的作用.
- 突出Saccharomyces cerevisiae作为研究基因组不稳定性的模型的实用性.
主要方法:
- 关于突变率,突变体表型和基因组不稳定性的现有文献的审查.
- 讨论在酵母中进行记者测试以检测基因组改变.
- 在酵母和更高的真核生物中对突变因子活动的比较分析.
主要成果:
- 突变具有双重作用:驱动进化和导致疾病.
- 突变现象型在癌症的发展和适应中至关重要.
- 酵母模型提供了对人类癌症相关的基因组不稳定性机制的见解.
结论:
- 了解突变体和抗突变体活动是控制癌症的关键.
- 需要对自发突变率和遗传完整性的进一步研究.
- 细菌菌是一种有价值的模型,用于研究与癌症相关的基因组不稳定性.
相关概念视频
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Mutations
82.8K
Overview
82.8K


